dRx Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 4
Professionals
  • Investments
  • 35
  • Portfolio
  • 20
  • Exits
  • 3
Exits

dRx Capital General Information

Description

Founded in 2015, dRx Capital is Novartis' Digital Health Venture Fund investing in entrepreneurs transforming healthcare through data and digital technology. The fund, backed by Novartis, invests in technology platforms improving access to healthcare and reimagining the practice of medicine, with a focus on AI & ML, big data, R&D optimization, patient care, and pharma supply chain and commercialization.

Contact Information

Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Corporate Venture Capital
Primary Office
  • Novartis Campus
  • 4056 Basel
  • Switzerland

dRx Capital Investments (35)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cala Health 16-Nov-2021 Later Stage VC 000.00 Therapeutic Devices Generating Revenue
00000000 10-Nov-2021 00000 00000 000.00 Database Software Generating Revenue 0000 000000
0000000 09-Nov-2021 00000 00000 0000 Other Healthcare Technology Systems Product Development
0000000 00 07-Oct-2021 0000 00000 Enterprise Systems (Healthcare) Generating Revenue 0000 000000
0000.00 21-Sep-2021 00000 00000 0000 Business/Productivity Software Generating Revenue 0000 000000 00.0
000000000 02-Sep-2021 0000 00000 Diagnostic Equipment Profitable 00000 000000
0000000 22-Jun-2021 00000 00000 0000 Monitoring Equipment Generating Revenue 0000 000000 00.0
0000 000000000000 22-Jun-2021 0000 00000 Other Healthcare Technology Systems Generating Revenue 0000 000000
Flywheel 26-Jan-2021 Later Stage VC 000.00 Database Software Generating Revenue 0000 000000
Peptone 08-Jan-2021 Seed Round 00.000 Decision/Risk Analysis Generating Revenue 0000 000000
You’re viewing 10 of 35 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

dRx Capital Exits (3)

Company Name Exit Date Exit Type Exit Size
Science 37 07-Oct-2021 Reverse Merger 00000
000000000 02-Sep-2021 0000000 000000 00000
You’re viewing 2 of 3 exits. Get the full list »

dRx Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

dRx Capital Team (9)

Name Title Deals Funds Boards Office
Eric Boutin Managing Director 0 0 Cambridge, MA
Chris Leiter Principal 0 San Francisco, CA
Rana Lonnen Ph.D Managing Director 0 0 Basel, Switzerland
You’re viewing 3 of 9 team members. Get the full list »

dRx Capital Co-Investors (134)

Name With Exits Lead Partner Series Industry
Novartis Pharma 7 0 Series chart Industry bar
McKesson Ventures 0 0 Series chart Industry bar
GV 0 0 0 Series chart Industry bar
Lux Capital 0 0 0 Series chart Industry bar
Section 32 0 0 Series chart Industry bar
You’re viewing 5 of 134 co-investors. Get the full list »